Isocyanide-based four-component synthesis of ferrocenyl 1,5-disubstituted tetrazoles

[1]  P. Mirzaei,et al.  A simple four-component synthesis of ferrocenyl amidodiesters and ferrocenyl triamides , 2011 .

[2]  P. Patil,et al.  Three-component strategy toward 5-membered heterocycles from isocyanide dibromides. , 2011, Organic letters.

[3]  G. T. Cin,et al.  Synthesis of novel ferrocenyl-containing pyrazolo[4,3-c]quinolines , 2011 .

[4]  K. Maitra,et al.  Synthesis and Characterization of New, Chiral P−N Ligands and Their Use in Asymmetric Allylic Alkylation , 2010 .

[5]  P. Mirzaei,et al.  A simple synthesis of ferrocenyl bis-amides by a Ugi four-component reaction , 2010 .

[6]  A. Bazgir,et al.  An efficient synthesis of ferrocenyl imidazo[1,2-a]pyridines , 2010 .

[7]  R. Borisov,et al.  Concise approach toward tetrazolo[1,5-a][1,4]benzodiazepines via a novel multicomponent isocyanide-based condensation. , 2010, Organic letters.

[8]  L. Grimaud,et al.  Beyond the Ugi reaction: less conventional interactions between isocyanides and iminium species , 2009 .

[9]  A. Csámpai,et al.  Synthesis, IR-, NMR-, DFT and X-ray study of ferrocenyl heterocycles from thiosemicarbazones. Part 21: Study on ferrocenes , 2007 .

[10]  Metin Zora,et al.  Synthesis of ferrocenyl pyrazoles by the reaction of (2-formyl-1-chlorovinyl)ferrocene with hydrazines , 2007 .

[11]  M. M. Abd-Elzaher,et al.  On the medicinal chemistry of ferrocene , 2007 .

[12]  T. Torroba,et al.  The use of the Ugi four-component condensation , 2007, Nature Protocols.

[13]  A. Lough,et al.  Synthesis, structural characterisation and biological activity of novel N -(ferrocenylmethyl)benzene-carboxamide derivatives , 2007 .

[14]  Haibo Yu,et al.  Synthesis and biological activity research of novel ferrocenyl-containing thiazole imine derivatives , 2007 .

[15]  O. Ivashkevich,et al.  Metal derivatives of tetrazoles , 2006 .

[16]  H. Dai,et al.  Synthesis and biological activities of new 1H-1,2,4-triazole derivatives containing ferrocenyl moiety , 2006 .

[17]  Sébastien Gonnard,et al.  A new and versatile Ugi/SNAr synthesis of fused 4,5-dihydrotetrazolo[1,5-a]quinoxalines , 2006 .

[18]  Yoshinori Yamamoto,et al.  Synthesis of 1-substituted tetrazoles via the acid-catalyzed [3+2] cycloaddition between isocyanides and trimethylsilyl azide , 2004 .

[19]  G. Leclercq,et al.  The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer. , 2004, Current medicinal chemistry.

[20]  W. Hiller,et al.  Synthesis of tetrazolopiperazine building blocks by a novel multi-component reaction , 2004 .

[21]  J. Lewkowski,et al.  α-(Ferrocenyl)-aminomethanephosphonous acids. First synthesis and preparation of their esters with cholesterol and adenosine , 2004 .

[22]  G. Leclercq,et al.  Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer ce , 2003, Chemistry.

[23]  P. Wilairat,et al.  Antimalarial activity of ferrocenyl chalcones. , 2002, Bioorganic & medicinal chemistry letters.

[24]  S. Bella.  Second-order nonlinear optical properties of transition metal complexes , 2001 .

[25]  Z. Chohan,et al.  Synthesis, characterization, coordination and antibacterial properties of novel asymmetric 1,1′-disubstituted ferrocene-derived Schiff-base ligands and their Co(II), Cu(II) Ni(II) and Zn(II) complexes , 2001 .

[26]  C. Biot,et al.  In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites , 2001, Parasitology Research.

[27]  Z. Chohan,et al.  Synthesis, characterization and antibacterial properties of symmetric 1,1′-ferrocene derived Schiff-base ligands and their Co(II), Cu(II), Ni(II) and Zn(II) chelates , 2000 .

[28]  S. Féry-Forgues,et al.  Ferrocene and ferrocenyl derivatives in luminescent systems , 2000 .

[29]  C. Biot,et al.  Novel metallocenic compounds as antimalarial agents. Study of the position of ferrocene in chloroquine , 1999 .

[30]  C. Richards,et al.  Recent advances in the generation of non-racemic ferrocene derivatives and their application to asymmetric synthesis , 1998 .

[31]  C. Biot,et al.  In Vitro Antimalarial Activity of a New Organometallic Analog, Ferrocene-Chloroquine , 1998, Antimicrobial Agents and Chemotherapy.

[32]  C. Biot,et al.  Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. , 1997, Journal of medicinal chemistry.

[33]  G. Jaouen,et al.  FACILE ROUTE TO FERROCIFEN, 1-4-(2-DIMETHYLAMINOETHOXY)-1-(PHENYL-2-FERROCENYL-BUT-1-ENE), FIRST ORGANOMETALLIC ANALOGUE OF TAMOXIFEN, BY THE MCMURRY REACTION , 1997 .

[34]  Alan R. Katritzky,et al.  Comprehensive Heterocyclic Chemistry IV , 1996 .

[35]  A. Vessières,et al.  Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics , 1996 .

[36]  S. Wittenberger.  RECENT DEVELOPMENTS IN TETRAZOLE CHEMISTRY. A REVIEW , 1994 .

[37]  E. Constable.  Sandwiches Bring a New Element to Molecular Recognition , 1991 .

[38]  Garland R. Marshall,et al.  Conformational mimicry. 1. 1,5-Disubstituted tetrazole ring as a surrogate for the cis amide bond , 1988 .

[39]  A. S. Chawla,et al.  Medicinal chemistry of tetrazoles. , 1980, Progress in medicinal chemistry.

[40]  T. J. KEALY,et al.  A New Type of Organo-Iron Compound , 1951, Nature.